Wang Shu-Bei, Chen Jia-Yi, Xu Cheng, Cao Wei-Guo, Cai Rong, Cao Lu, Cai Gang
Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Front Oncol. 2022 Oct 27;12:1040495. doi: 10.3389/fonc.2022.1040495. eCollection 2022.
Many studies have shown that the peripheral blood inflammatory index and nutritional index, such as the platelet lymphocyte ratio (PLR), neutrophil lymphocyte ratio (NLR), lymphocyte monocyte ratio (LMR), systemic inflammation response index (SIRI), pan-immune-inflammation value (PIV), systemic immune-inflammation index (SII), and prognostic nutrition index (PNI), are independent prognostic factors for tumors. The present study aimed to investigate the prognostic role of these peripheral blood indexes before treatment in locally advanced gastric cancer (LAGC) treated with adjuvant chemoradiotherapy after D2 dissection.
A total of 89 patients with LAGC who underwent D2 gastrectomy and adjuvant chemoradiotherapy at our hospital from 2010-2018 were eligible. Systemic inflammatory indicators before treatment were evaluated. Receiver operating characteristic curve (ROC), Kaplan-Meier analysis, and Cox regression were utilized for prognosis evaluation.
The median follow-up time was 29.1 (4.1-115.8) months. The overall survival at 3 years (OS) and the disease-free survival (DFS) were 78.9% and 59.1%, respectively. According to the ROC curve for 3-year DFS, the best cut-off values of pre-treatment NLR, PLR, LMR, SII, SIRI, PIV and PNI were 1.7, 109.3, 2.9, 369.2, 0.58, 218.7, and 48, respectively. Multivariate Cox regression analysis showed that NLR was an independent prognostic factor for DFS (HR 2.991, 95%CI 1.085-8.248, 0.034). Kaplan-Meier analysis showed that a higher NLR (>1.70) was significantly associated with a poorer OS (3-year OS: 68.8% vs 92.9%, 0.045) and DFS (3-year DFS: 47.5% vs 80.9%, 0.005). In terms of the free locoregional recurrence rate (LRR), the prognosis of patients with high NLR was also significantly worse than those with low NLR (70.2% vs 96.0%, 0.017). Paraaortic lymph nodes were the most common site of LRR (7/14 patients). The seven cases of paraaortic lymph node metastasis occurred in patients with high NLR.
In our retrospective analysis, we found that pretreatment NLR could serve as a prognostic factor for survival in LAGC treated with adjuvant chemoradiotherapy after D2 dissection, especially for the prediction of LRR and paraaortic lymph node metastasis. Prospective studies are needed to confirm our findings.
许多研究表明,外周血炎症指标和营养指标,如血小板淋巴细胞比率(PLR)、中性粒细胞淋巴细胞比率(NLR)、淋巴细胞单核细胞比率(LMR)、全身炎症反应指数(SIRI)、全免疫炎症值(PIV)、全身免疫炎症指数(SII)和预后营养指数(PNI),是肿瘤的独立预后因素。本研究旨在探讨这些外周血指标在接受D2淋巴结清扫术后辅助放化疗的局部晚期胃癌(LAGC)治疗前的预后作用。
2010年至2018年在我院接受D2胃切除术和辅助放化疗的89例LAGC患者符合条件。评估治疗前的全身炎症指标。采用受试者工作特征曲线(ROC)、Kaplan-Meier分析和Cox回归进行预后评估。
中位随访时间为29.1(4.1 - 115.8)个月。3年总生存率(OS)和无病生存率(DFS)分别为78.9%和59.1%。根据3年DFS的ROC曲线,治疗前NLR、PLR、LMR、SII、SIRI、PIV和PNI的最佳截断值分别为1.7、109.3、2.9、369.2、0.58、218.7和48。多因素Cox回归分析显示,NLR是DFS的独立预后因素(HR 2.991,95%CI 1.085 -
8.248,P = 0.034)。Kaplan-Meier分析显示,较高的NLR(>1.70)与较差的OS(3年OS:68.8%对92.9%,P = 0.045)和DFS(3年DFS:47.5%对80.9%,P = 0.005)显著相关。就局部区域复发率(LRR)而言,高NLR患者的预后也明显差于低NLR患者(70.2%对96.0%,P = 0.017)。腹主动脉旁淋巴结是LRR最常见的部位(14例患者中有7例)。7例腹主动脉旁淋巴结转移发生在高NLR患者中。
在我们的回顾性分析中,我们发现治疗前NLR可作为D2淋巴结清扫术后辅助放化疗的LAGC患者生存的预后因素,特别是对于LRR和腹主动脉旁淋巴结转移的预测。需要前瞻性研究来证实我们的发现。